Company Description
Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America.
It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee’s, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Its Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names.
The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands.
Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
| Country | United States |
| Founded | 2022 |
| IPO Date | May 4, 2023 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 22,000 |
| CEO | Kirk Perry |
Contact Details
Address: 1 Kenvue Way Summit, New Jersey 07901 United States | |
| Website | kenvue.com |
Stock Details
| Ticker Symbol | KVUE |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $22.00 |
| CIK Code | 0001944048 |
| CUSIP Number | 49177J102 |
| ISIN Number | US49177J1025 |
| Employer ID | 88-1032011 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Kirk L. Perry | Interim Chief Executive Officer and Director |
| Meredith Stevens | Chief Operations Officer |
| Carlton Lawson | Group President of EMEA and Latin America |
| Ellie Bing Xie | Executive Officer |
| Amit Banati | Chief Financial Officer |
| Heather R. Howlett | Chief Accounting Officer |
| Bernardo Tavares | Chief Data and Technology Officer |
| Dr. Caroline Tillett Ph.D. | Chief Scientific Officer |
| Sofya Tsinis | Head of Investor Relations |
| Matthew Orlando | General Counsel |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 29, 2025 | SCHEDULE 13G/A | Filing |
| Jul 14, 2025 | 8-K | Current Report |
| Jun 24, 2025 | 8-K | Current Report |
| Jun 2, 2025 | SD | Form - SD |
| May 27, 2025 | 8-K | Current Report |
| May 22, 2025 | 8-K | Current Report |
| May 21, 2025 | 424B2 | Prospectus |
| May 21, 2025 | 8-K | Current Report |
| May 20, 2025 | FWP | Free Writing Prospectus |
| May 20, 2025 | 424B5 | Filing |